The NAD+ supplement market is fragmented, pill-dependent, and compliance-broken. SIRTS is the RTD format built for the consumer who already believes in the science — and needs a product worthy of their daily protocol.
No commitment. We'll follow up with the full deck.
RAISE PROGRESS
$45,000
committed of $400,000 goal
12 investors have expressed interest
$400K
RAISE TARGET
SAFE
INSTRUMENT
$3.5M
VALUATION CAP
$500
MIN. CHECK SIZE
01 — The opportunity
The market is ready. The format didn't exist.
The global NAD+ supplement market is projected to reach $1.1B by 2028. NR-based products currently dominate the capsule category — but no brand has successfully translated the science into a daily RTD with consumer-grade brand identity and distribution.
The biohacker-adjacent consumer — 32 to 58, educated, protocol-oriented — already purchases $80–$150/month in longevity supplements. They are not price-sensitive. They are compliance-sensitive. SIRTS solves that.
Global NAD+ supplement market (2028 proj.)
$1.1B
CAGR 11.4%
US functional beverage market
$68B
2024 estimate
Avg. monthly longevity supplement spend
$120
per person
RTD health beverage growth rate
8.9%
YoY CAGR
Capsule compliance at 90 days
40–60%
industry average
02 — Traction
Pre-revenue. Not pre-signal.
1,000
FOUNDING SPOTS OPEN
Pre-order waitlist live. 237 founding members reserved with zero paid acquisition.
ITU
TRADEMARK FILED
USPTO serial 99804789, IC 032. Filed 05/05/2026. Brand IP secured before market entry.
1
SKU COMPLETE
Full can design, brand identity, and positioning ready. Production-ready single-SKU formula finalized.
$0
PAID CAC
All traction generated organically. Clean baseline before any media spend.
03 — Use of funds
$400K gets SIRTS to first shipment.
This raise covers everything required to go from founding member pre-orders to physical product in hand. No runway padding, no overhead inflation.
01
Co-packer deposit & first production run
NR-based RTD formulation, initial small-batch run for founding members
$120K
48%
02
Regulatory & compliance
FDA labeling, USPTO Statement of Use, legal, insurance
$35K
14%
03
DTC infrastructure
Shopify, Klaviyo, fulfillment setup, cold chain
$30K
12%
04
Paid acquisition — launch sprint
Meta, TikTok, influencer seeding in longevity & biohacker verticals
$40K
16%
05
Content & brand production
Photography, video, The Pathway editorial newsletter
$15K
6%
06
Reserve
Working capital buffer and unexpected production costs
$10K
4%
04 — Deal terms
Simple terms. Standard instrument.
We're using a SAFE — the same instrument Y Combinator pioneered. No complex cap table negotiation. Clean, founder-friendly, investor-understood.
01
SAFE
INSTRUMENT
Simple Agreement for Future Equity — the same instrument Y Combinator pioneered. No complex cap table negotiation. No interest. No maturity date.
02
$3.5M
POST-MONEY VALUATION CAP
Your investment converts at the lower of the cap or the price in a future priced round. Protects early investors from dilution at higher valuations.
03
$500
MINIMUM CHECK SIZE
We want founding investors to include the people who believe in this brand at every level. Not just institutions.
05 — The team
Built by operators who know the craft.
RD
Rovane Durso
Founder — Brand, Digital, Product
Founder of Durso Design LLC. Brand strategy, UX, and digital design across consumer products. Co-founder of Inception Creative, a luxury beauty brand agency. Brings design-as-moat thinking to SIRTS — the product identity is the competitive advantage.
SS
Sean Sharifi
Adviser
Co-founder of Inception Creative (inceptioncreative.agency). Specializes in luxury beauty brand development and go-to-market strategy. Background in premium consumer brand building, agency operations, and scaling early-stage creative businesses.
Seed round · SAFE · $400K target
Invest in SIRTS. Back the category.
Express your interest below. No commitment — we'll follow up with the full investor deck, financials, and next steps.